In a clinically node negative early stage breast cancer patient who underwent neoadjuvant systemic therapy, would surgical finding of fibrosis suspicious for treatment effect in sentinel nodes impact your RT decision?
1
1 Answers
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
I would treat breast only for most of these patients with favorable early-stage disease. More so with B-51 not showing benefit even in clinical positive becoming negative.
In a clinically node negative early stage breast cancer patient who underwent neoadjuvant systemic therapy, would surgical finding of fibrosis suspicious for treatment effect in sentinel nodes impact your RT decision? | Mednet
